Red Tree Management, LLC
Red Tree Management, LLC is a Pre-seed, Seed, Series A and Series C+ fund in US-West investing in therapeutics, oncology, neurology, immunology, drug-discovery and healthcare-tech.
- Stages
- Pre-seed, Seed, Series A, Series C+
- Sectors
- therapeutics, oncology, neurology, immunology, drug-discovery, healthcare-tech
- Invests in
- US-West
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $272M
Check size not disclosed
Thesis
It focuses on early-stage life science companies, particularly those developing first-in-class or best-in-class therapeutics for oncology, neurology, and immunology, addressing significant unmet medical needs. The firm leverages its connections with West Coast academic and research institutions. They often lead or co-lead financing rounds. Red Tree Venture Capital Fund I closed at $272 million in June 2022. Their second fund, Red Tree Venture Fund II, L.P., had a first close of $133.3 million in January 2024, targeting $350 million. The firm's most recent portfolio value was $111,825,533 USD as of March 31, 2026. The firm is headquartered in Redwood City, California.
Common questions
Does Red Tree Management, LLC invest at the Pre-seed stage?
Yes. Red Tree Management, LLC lists Pre-seed, Seed, Series A and Series C+ among the stages it invests in.
Where does Red Tree Management, LLC invest?
Red Tree Management, LLC invests in US-West.